Acadia Healthcare (NASDAQ:ACHC) Trading 21.9% Higher – Here’s Why

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price rose 21.9% during trading on Tuesday . The company traded as high as $13.89 and last traded at $14.2350. Approximately 1,678,534 shares were traded during trading, a decline of 37% from the average daily volume of 2,675,270 shares. The stock had previously closed at $11.68.

Analyst Ratings Changes

Several brokerages recently commented on ACHC. Cowen reissued a “reduce” rating on shares of Acadia Healthcare in a research report on Friday. Barclays cut their price objective on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating for the company in a report on Thursday, December 4th. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, Mizuho lowered their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $18.92.

Acadia Healthcare Stock Up 24.2%

The firm has a market cap of $1.34 billion, a price-to-earnings ratio of 12.38, a P/E/G ratio of 3.06 and a beta of 0.88. The firm has a fifty day simple moving average of $14.64 and a 200-day simple moving average of $19.84. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The business had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. During the same quarter in the previous year, the firm posted $0.91 EPS. Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Institutional Trading of Acadia Healthcare

Several large investors have recently modified their holdings of ACHC. Abrams Bison Investments LLC raised its stake in Acadia Healthcare by 96.7% in the second quarter. Abrams Bison Investments LLC now owns 3,580,000 shares of the company’s stock valued at $81,230,000 after purchasing an additional 1,760,000 shares in the last quarter. Deerfield Management Company L.P. acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at approximately $29,440,000. Rubric Capital Management LP acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $27,236,000. Wellington Management Group LLP increased its stake in Acadia Healthcare by 11.8% in the third quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock valued at $233,327,000 after acquiring an additional 993,205 shares during the last quarter. Finally, Amundi raised its position in Acadia Healthcare by 1,006,804.5% during the second quarter. Amundi now owns 896,145 shares of the company’s stock valued at $20,782,000 after purchasing an additional 896,056 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.